Publication:
Development and characterization of vancomycin-loaded levan-based microparticular system for drug delivery

dc.contributor.authorSEZER, ALİ DEMİR
dc.contributor.authorTOKSOY ÖNER, EBRU
dc.contributor.authorRAYAMAN, ERKAN
dc.contributor.authorsSezer, Ali Demir; Sarilmiser, Hande Kazak; Rayaman, Erkan; Cevikbas, Adile; Oner, Ebru Toksoy; Akbuga, Julide
dc.date.accessioned2022-03-12T20:32:03Z
dc.date.accessioned2026-01-10T16:56:58Z
dc.date.available2022-03-12T20:32:03Z
dc.date.issued2017
dc.description.abstractEncapsulation of vancomycin (VANCO) into biodegradable levan microparticles was achieved using a simple preparation technique. Microparticles were prepared by using levan polysaccharide produced by a halophilic bacterium Halomonas smyrnensis AAD6(T). To optimize efficiency of encapsulation process by precipitation method, three parameters were studied: drug and polymer concentrations and preparation rotating speed. The particles were characterized in vitro. The size of levan microparticles was changed between 0.404 mu m and 1.276 mu m. The surface charge was detected between +4.1 mV and +6.5 mV. The highest drug encapsulation capacity of the system was 74.7% and was depending on the polymer concentration. In dissolution studies, initial burst effect around 10-20% from all the formulations was observed and then the release was slowed down and continued at a constant level. In vitro antibiotic release from the microparticles was controlled with the drug carrier system and release fit to Higuchi kinetic model. All the released samples collected at different time intervals during dissolution studies have exhibited intrinsic bactericidal activity against Bacillus subtilis ATCC 6633. WST-1 cell proliferation and viability studies showed that VANCO-loaded levan microparticles at concentrations between 100 mu g/mL and 1000 mu g/mL were nontoxic to L929 cells. As conclusion, levan microparticulate system could be a potential carrier of antibiotic drugs such as VANCO.
dc.identifier.doi10.3109/10837450.2015.1116564
dc.identifier.eissn1097-9867
dc.identifier.issn1083-7450
dc.identifier.pubmed26607946
dc.identifier.urihttps://hdl.handle.net/11424/234355
dc.identifier.wosWOS:000402312400001
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS LTD
dc.relation.ispartofPHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectControlled release
dc.subjectlevan
dc.subjectmicroparticle
dc.subjectpolysaccharide
dc.subjectvancomycin
dc.subjectCOLON-SPECIFIC DELIVERY
dc.subjectIN-VITRO
dc.subjectNANOPARTICLES
dc.subjectMICROSPHERES
dc.subjectRELEASE
dc.subjectFILMS
dc.subjectBIOPOLYMER
dc.subjectPARAMETERS
dc.subjectPARTICLES
dc.subjectSUBSTRATE
dc.titleDevelopment and characterization of vancomycin-loaded levan-based microparticular system for drug delivery
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage634
oaire.citation.issue5
oaire.citation.startPage627
oaire.citation.titlePHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
oaire.citation.volume22

Files